ANI Pharmaceuticals Executive and Leadership Team

Nikhil Lalwani, the President & Chief Executive Officer at ANI Pharmaceuticals, directs the overarching corporate strategy and long-term growth initiatives. Lalwani architects the expansion of the Purified Cortrophin Gel franchise while overseeing the integration of enhanced development capabilities across the entire generics business. By aligning internal resources with market demands, the President & Chief Executive Officer ensures the company maintains a competitive edge in the bio-pharmaceutical sector. Nikhil Lalwani drives the execution of high-level operational goals, fostering innovation within established brands to maximize shareholder value. Through consistent engagement with the Board and senior leadership, the President & Chief Executive Officer secures the necessary capital and infrastructure to support sustainable scaling. This leadership role involves navigating complex regulatory landscapes to ensure consistent product delivery. Ultimately, Lalwani strengthens the market position of the organization by prioritizing patient needs and operational excellence.

Samy Shanmugam, the Chief Operating Officer & Head of Research Development & NJ Operations at ANI Pharmaceuticals, oversees the technical execution of pharmaceutical manufacturing and research pipelines. Shanmugam directs the daily operations at the New Jersey facilities, ensuring strict adherence to quality standards and production timelines. By optimizing the research and development lifecycle, the Chief Operating Officer & Head of Research Development & NJ Operations accelerates the delivery of new generic and branded products to the market. Samy Shanmugam coordinates cross-functional teams to streamline supply chain logistics and manufacturing efficiency across North American sites. This leadership role involves managing complex technical projects that directly impact the company's ability to scale production. Through rigorous oversight of operational workflows, the Chief Operating Officer & Head of Research Development & NJ Operations maintains high standards of product integrity. Shanmugam drives continuous improvement initiatives, ensuring the organization remains agile in a rapidly evolving pharmaceutical landscape.

Krista Davis, the Senior Vice President, Chief Human Resources Officer at ANI Pharmaceuticals, manages the organizational culture and talent acquisition strategies essential for bio-pharmaceutical success. Davis designs comprehensive workforce development programs that support the manufacturing and research teams. By implementing robust performance management systems, the Senior Vice President, Chief Human Resources Officer ensures alignment between individual employee contributions and corporate growth objectives. Krista Davis cultivates an environment of innovation, attracting top-tier scientific and operational talent to bolster the company's North American manufacturing capabilities. This leadership role involves collaborating with executive peers to refine organizational structure and improve internal communication channels. Through strategic workforce planning, the Senior Vice President, Chief Human Resources Officer mitigates operational risks and enhances employee retention. Davis drives initiatives that promote professional development, ensuring the organization possesses the human capital required to sustain long-term pharmaceutical innovation and market expansion.

Mary Pao, the Chief Medical Officer at ANI Pharmaceuticals, leads the clinical strategy and medical oversight for the entire product portfolio. Pao evaluates the safety and efficacy of all pharmaceutical offerings, ensuring compliance with rigorous healthcare standards. By guiding the clinical development process, the Chief Medical Officer provides the scientific foundation necessary for the successful launch of new branded and generic products. Mary Pao collaborates with regulatory bodies and internal research teams to validate therapeutic outcomes and support the company's mission of serving patients in need. This leadership role involves interpreting complex medical data to inform strategic business decisions and product positioning. Through the management of clinical trials and medical affairs, the Chief Medical Officer ensures that all products meet the highest quality benchmarks. Pao drives the integration of medical expertise into the broader corporate strategy, ultimately enhancing the reputation and clinical impact of the organization within the competitive pharmaceutical industry.